{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-056835","form_type":"8-K","ticker":"VYGR","cik":"0001640266","company_name":"Voyager Therapeutics, Inc.","filed_at":"2025-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.166740+00:00","generated_at":"2026-05-19T22:01:38.166843+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Voyager stockholders approve 2025 stock plans, elect directors at annual meeting","bullets":["Approved 2025 Stock Incentive Plan: 28.6M for, 11.3M against, 8.5M broker non-votes.","Approved Amended and Restated 2015 ESPP: 36.5M for, 3.3M against, 8.5M broker non-votes.","Elected Class I directors Colón, Mackey, Pierce, Scangos; Scangos had 6.7M votes withheld.","Ratified Ernst & Young as FY2025 auditor: 48.1M for, 0.25M against.","Say-on-pay approved: 37.8M for, 2.0M against, 0.1M abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-056835","json":"https://secwatch.observer/filing/0001104659-25-056835.json","markdown":"https://secwatch.observer/filing/0001104659-25-056835.md","text":"https://secwatch.observer/filing/0001104659-25-056835.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056835/0001104659-25-056835-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056835/tm2517216d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T22:01:38.166843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}